Publication | Closed Access

Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular disease

ThrombosisHypertensionCardiovascular DiseaseBlood PlateletStrokePharmacologyHematologyPlatelet ActivityRenin InhibitorHemostasisPlatelet AntagonistVascular BiologyPharmacotherapyFibrinolysisMultiple Risk FactorsMedicineAnticoagulantAtherosclerosis